Mesenchymal stromal cells from adipose tissue (ADāMSCs) exhibit favorable clinical traits for autologous transplantation and can develop āSchwannālikeā phenotypes (sADāMSCs) to improve peripheral nerve regeneration, where severe injuries yield insufficient recovery. However, sADāMSCs regress without biochemical stimulation and detach from conduits under unfavorable transplant conditions, negating their paracrine effects. Grapheneāderived materials support ADāMSC attachment, regulating cell adhesion and function through physiochemistry and topography. Graphene oxide (GO) is a suitable substrate for human sADāMSCs incubation toward severe peripheral nerve injuries by evaluating transcriptome changes, neurotrophic factor expression over a 7ādays period, and cell viability in apoptotic conditions is reported. Transcriptome changes from GO incubation across four patients are minor compared to biological variance. Nerve growth factor (NGF), braināderived neurotrophic factor (BDNF), and glialāderived neurotrophic factor (GDNF) gene expression is unchanged from sADāMSCs on GO substrates, but NGF and GDNF protein secretion increase at day 3 and 7. Secretome changes do not improve dorsal root ganglia neuron axon regeneration in conditioned media culture models. Fewer sADāMSCs detach from GO substrates compared to glass following phosphate buffer saline exposure, which simulates apoptotic conditions. Overall, GO substrates are compatible with sADāMSC primed for peripheral nerve regeneration strategies and protect the cell population in harsh environments.